La vendita allo scoperto per Carlyle Secured Lending dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Carlyle Secured Lending. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Carlyle Secured Lending (NASDAQ:CGBD) Azioni, Report sulle vendite allo scoperto

Carlyle Secured Lending

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Carlyle Secured Lending, Inc. - Closed End Fund

Carlyle Secured Lending Inc

Carlyle Secured Lending, Inc. - 8.20% Notes due 2028

News

Guidance

Kennametal Sees Q2 Revenues Of $480M-$500M Vs. $492.97M Estimate; And Adjusted EPS Of $0.20-$0.30 Vs. $0.27 Estimate

HC Wainwright &amp; Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIU#NASDAQ">ACIU</a>) with a Buy and maintains $16 price target.

Price Target

Reiteration

Analyst Ratings

ACIU

HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target

Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) reported quarterly earnings of $3.34 per share which beat the analyst consensus estimate of $3.22 by 3.73 percent. This is a 16.78 percent increase over earnings of $2.86 per share from the same period last year. The company reported quarterly sales of $79.05 billion which beat the analyst consensus estimate of $77.65 billion by 1.80 percent. This is a 14.70 percent increase over sales of $68.92 billion the same period last year.

Earnings

Cencora Q4 2024 Adj EPS $3.34 Beats $3.22 Estimate, Sales $79.05B Beat $77.65B Estimate

Bookings were $3.82 billion, representing a book-to-bill ratio of 104.4% or 109.3% on a trailing twelve-month basis.&nbsp;
Bookings were $3.82 billion, representing a book-to-bill ratio of 104.4% or 109.3% on a trailing twelve-month basis.
 &nbsp;

CGI's Q4 Bookings Were $3.82B For A Book-To-Bill Ratio Of 104.4%

The Company now expects its fiscal 2024 organic net sales and reported net sales outlooks towards the lower end of its previously stated ranges of organic net sales growth versus the prior year of -3% to -1% and reported net sales growth versus the prior year of -5% to -3%.&nbsp;

PRGO

Perrigo Now Expects FY24 Organic Net Sales And Reported Net Sales Outlooks Towards Lower End Of Its Previously Stated Ranges

Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.26 by 11.54 percent. The company reported quarterly sales of $481.948 million which missed the analyst consensus estimate of $484.074 million by 100.00 percent. This is a 100.00 percent decrease over sales of $492.476 million the same period last year.

Earnings Beats

Earnings Misses

Kennametal Q1 2025 Adj. EPS $0.29 Beats $0.26 Estimate, Sales $481.948M Miss $484.074M Estimate

Dividends

GPUS

Hyperscale Data Announced That It Plans To Issue A $16.25M Stated Value Special Dividend of 10% Series E Cumulative Redeemable Perpetual Preferred Stock

Perrigo Reaffirms FY24 Adjusted EPS Outlook Of $2.50 - $2.65, Est $2.57

WIIM

CVS shares are trading higher following a Q3 revenue beat.

Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) reported quarterly losses of $(2.44) per share which missed the analyst consensus estimate of $(1.01) by 141.58 percent. The company reported quarterly sales of $1.335 billion which beat the analyst consensus estimate of $1.329 billion by 0.44 percent.

LINE

Lineage Q3 2024 GAAP EPS $(2.44) Misses $(1.01) Estimate, Sales $1.335B Beat $1.329B Estimate

CGI Q4 2024 Adj. EPS C$1.92 Beats C$1.91 Estimate, Sales C$3.660B Beat C$3.609B Estimate

Perrigo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $0.82 by 1.22 percent. This is a 26.56 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $1.09 billion which missed the analyst consensus estimate of $1.13 billion by 3.29 percent. This is a 3.20 percent decrease over sales of $1.12 billion the same period last year.

Perrigo Q3 2024 Adj EPS $0.81 Misses $0.82 Estimate, Sales $1.09B Miss $1.13B Estimate

Transaction Details
Cencora will acquire RCA for approximately $4.6 billion in cash, subject to a customary working capital and net-debt adjustment. RCA's affiliated practices, physicians and management will retain a minority interest in RCA, with Cencora holding approximately 85% ownership in RCA upon closing. Additionally, Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal year 2027 and fiscal year 2028, subject to the successful completion of certain predefined business objectives.

Health Care

General

Cencora Has Agreed To Acquire Retina Consultants Of America From Webster Equity Partners For Approximately $4.6B In Cash

Benchmark analyst David Williams reiterates Alpha &amp; Omega (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) with a Buy and maintains $40 price target.

AOSL

Benchmark Reiterates Buy on Alpha & Omega, Maintains $40 Price Target

MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.83 by 3.83 percent. The company reported quarterly sales of $206.715 million which beat the analyst consensus estimate of $206.245 million by 0.23 percent. This is a 19.99 percent increase over sales of $172.284 million the same period last year.

MKTX

MarketAxess Holdings Q3 2024 GAAP EPS $1.90 Beats $1.83 Estimate, Sales $206.715M Beat $206.245M Estimate

CVS Health Q3 2024 Adj. EPS $1.09 Misses $1.53 Estimate, Sales $95.428B Beat $92.747B Estimate

Regis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NYSE">RGS</a>) reported quarterly losses of $(0.36) per share. This is a 160 percent decrease over earnings of $0.60 per share from the same period last year. The company reported $46.06 million in sales this quarter. This is a 13.70 percent decrease over sales of $53.37 million the same period last year.

Regis Q1 EPS $(0.36) Down From $0.60 YoY, Sales $46.06M Down From $53.37M YoY

Global leaders have begun extending their congratulations to Donald Trump following <a href="https://www.benzinga.com/news/24/11/41766547/trump-gives-victory-speech-in-florida-as-winning-pennsylvania-puts-him-at-brink-of-victory-vows-to-f">his anticipated victory in the U.S. presidential election</a>. This comes after a closely-watched contest where Trump emerged victorious over Democrat rival Kamala Harris, as declared by the Associated Press.
What Happened: Several prominent world leaders have reached out to Trump to offer their congratulations. President Volodymyr Zelenskyy of Ukraine expressed hope for continued bipartisan support from the U.S., emphasizing the strategic partnership between the two nations. Zelensky recalled a meeting with Trump in September, where they discussed efforts to end Russian aggression and praised Trump&#8217;s &#8220;peace through strength&#8221; approach.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Congratulations to <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> on his impressive election victory! I recall our great meeting with President Trump back in September, when we discussed in detail the Ukraine-U.S. strategic partnership, the Victory Plan, and ways to put an end to Russian aggression against…
&mdash; Volodymyr Zelenskyy / Володимир Зеленський (@ZelenskyyUa) <a href="https://twitter.com/ZelenskyyUa/status/1854073411904938032?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
India&#8217;s Prime Minister Narendra Modi also<a href="https://in.benzinga.com/government/24/11/41767384/narendra-modi-extends-congratulations-to-donald-trump-on-election-win-envisions-robust-india-us-part"> extended his congratulations on X, </a>expressing eagerness to strengthen the India-U.S. Comprehensive Global and Strategic Partnership. Modi emphasized collaboration for global peace and prosperity.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Heartiest congratulations my friend <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> on your historic election victory. As you build on the successes of your previous term, I look forward to renewing our collaboration to further strengthen the India-US Comprehensive Global and Strategic Partnership. Together,… <a href="https://t.co/u5hKPeJ3SY">pic.twitter.com/u5hKPeJ3SY</a>
&mdash; Narendra Modi (@narendramodi) <a href="https://twitter.com/narendramodi/status/1854075308472926675?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/11/41703542/mary-trump-on-trumps-lack-of-empathy-why-is-it-that-the-more-awful-things-donald-does-the-less-it-se?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mary Trump On Trump&#8217;s Lack Of Empathy: &#8216;Why Is It That The More Awful Things Donald Does, The Less It Seems To Matter?&#8217;</a>
French President Emmanuel Macron joined in, congratulating Trump and expressing readiness to continue their collaborative efforts for peace and prosperity. Macron highlighted their shared convictions and ambitions.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Congratulations, President <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a>. Ready to work together as we did for four years. With your convictions and mine. With respect and ambition. For more peace and prosperity.
&mdash; Emmanuel Macron (@EmmanuelMacron) <a href="https://twitter.com/EmmanuelMacron/status/1854073283420754221?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Israel&#8217;s Prime Minister Benjamin Netanyahu celebrated Trump&#8217;s victory as a historic comeback, expressing enthusiasm for the renewed alliance between Israel and the U.S. Netanyahu&#8217;s message on X highlighted the significance of Trump&#8217;s return to the White House.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Dear Donald and Melania Trump, Congratulations on history's greatest comeback! Your historic return to the White House offers a new beginning for America and a powerful recommitment to the great alliance between Israel and America. This is a huge victory! In true friendship,… <a href="https://t.co/B54NSo2BMA">pic.twitter.com/B54NSo2BMA</a>
&mdash; Benjamin Netanyahu &#8211; בנימין נתניהו (@netanyahu) <a href="https://twitter.com/netanyahu/status/1854070348926328965?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The 2024 U.S. presidential election was a highly anticipated event, with <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">Trump defeating Kamala Harris</a> to secure his victory. This election saw Sen. JD Vance (R-Ohio) becoming the new Vice President-elect. Vance, a Marine veteran and author of &#8220;Hillbilly Elegy,&#8221; adds a new dynamic to the administration. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41733346/obamas-former-campaign-manager-alarmed-by-early-voting-numbers-as-harris-trump-fight-close-battle-re?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Obama&#8217;s Former Campaign Manager Alarmed By Early Voting Numbers As Harris-Trump Fight Close Battle: &#8216;Repulicans Didn&#8217;t Do What They Did Last Time&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo via Shutterstock.

Politics

Global

Ukraine's Zelenskyy, Benjamin Netanyahu And Other Key World Leaders Congratulate Donald Trump On Election Victory

HC Wainwright &amp; Co. analyst Ed Arce maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Buy and raises the price target from $82 to $95.

RARE

HC Wainwright & Co. Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $95

HC Wainwright &amp; Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) with a Buy and lowers the price target from $9 to $5.

IPSC

HC Wainwright & Co. Maintains Buy on Century Therapeutics, Lowers Price Target to $5

Carlyle Secured Lending: 11% Yield And Merger-Driven Growth (Upgrade)

TCG BDC ( ($CGBD) ) has issued an update. Carlyle Secured Lending, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBD#NASDAQ">CGBD</a>) is set to release its third-quarter financial results on Nov...

Carlyle Secured Lending to Announce Q3 Results

Wells Fargo Sticks to Their Hold Rating for TCG BDC (CGBD)

Carlyle Secured Lending Q3 2024 Earnings Preview

Here are the major earnings after the close today

Carlyle Secured Lending reports Q3 results

Net asset value per common share decreased by 0.6% for Q3 to $16.85 from $16.95 as of June 30, 2024. The total fair value of the company's investme...

Carlyle Secured Lending reports Q3 adjusted NII 49c, consensus 48c

Carlyle Secured Lending stock slides after Q3 net investment income slips

The latest announcement is out from TCG BDC ( ($CGBD) ). Carlyle Secured Lending, Inc. announced strong third-quarter financial results with a net ...

TCG BDC Reports Strong Q3 Results and Dividend

Carlyle Secured Lending declares $0.40 dividend

ARCC

AVNW

BBAI

BCSF

BXSL

CGBD

CPNG

EOSE

EXAS

GMED

GPOR

IGIC

IRBT

JKHY

LAAC

LUMN

MASI

MCHP

MEGEF

MGNX

MRCY

NCMI

OBDC

PAAS

PAYS

QLYS

RVLV

RYAM

RYTM

SMCI

SNDX

STKL

TFPM

TRVG

TSLX

WTTR

Financing

Press Releases

Carlyle Secured Lending, Inc. Announces Merger with Carlyle Secured Lending III

CGBD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Carlyle Secured Lending, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, OB, CGBD on Behalf of Shareholders

Kuehn Law Encourages CGBD, DRQ, CBZ, and OB Investors to Contact Law Firm

INVESTIGATION ALERT: Halper Sadeh LLC Continues to Investigate CGBD, OB, TWKS on Behalf of Shareholders

CARLYLE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Carlyle Secured Lending, Inc. - CGBD

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRDI, BALY, CGBD on Behalf of Shareholders

Carlyle Secured Lending, Inc. Prices Public Offering of $300 Million 6.750% Unsecured Notes Due 2030

Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Third Quarter Ended September 30, 2024

Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended 2024, Declares Fourth Quarter 2024 Dividends of $0.45 Per Common Share

Comments

Carlyle Secured Lending

Vendite allo scoperto

Carlyle Secured Lending (NASDAQ:CGBD) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO